Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48.55 USD | -1.16% | +0.52% | -41.85% |
May. 29 | Truist Securities Lowers Price Target on Cytokinetics to $70 From $86, Maintains Buy Rating | MT |
May. 28 | Cytokinetics Closes $500 Million Stock Offering | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CYTOKINETICS, INCORPORATED | Bio Therapeutic Drugs | -1.16% | +0.52% | -41.85% | +28.81% | +368.18% | 5.57B |
Technical Rankings Surperformance
- Stock Market
- Equities
- CYTK Stock
- Charts Cytokinetics, Incorporated
- Comparison Chart